FED UP with Bleeding Disorders Act of 2026

The FED UP with Bleeding Disorders Act of 2026 was introduced on May 13, 2026, and referred to the House Committee on Energy and Commerce. It is in the earliest legislative stage with no hearings or markups scheduled. The bill directs the Secretary of Health and Human Services to conduct an interagency review and establish initiatives focused on bleeding disorders in underserved populations, particularly women. It does not authorize any specific dollar amount for appropriations; any future funding would require a separate appropriations bill. The bill's findings cite economic costs of heavy menstrual bleeding ($1B direct, $12B indirect annually) but do not create a direct funding stream or procurement program. No publicly traded companies are named or directly affected by the bill's provisions. The legislative path requires committee action, House passage, Senate passage, and presidential signature—a multi-year process with low probability in the current session. The bill's sponsors include a junior House member (Rep. Julie Johnson, D-TX) with only two cosponsors, indicating limited bipartisan momentum. Without authorized funding or a regulatory mandate targeting specific industries, the market impact is negligible.